Litcius/Paper detail

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse, Bala Başak Öven, Başak Oyan Uluç, Atike Gökçen Demiray, Di̇lek Erdem, Bilgin Demir, Nazım Serdar Turhal, Necdet Üskent, Sinem Akbaş, Fatih Selçukbırıcık, Ali İnal, Ahmet Bılıcı, Ömer Fatih Ölmez, Devrim Çabuk, Çağlar Ünal, Mutlu Hızal, Mehmet Alı Nahıt Şendur, Mustafa Korkmaz, Nuri Karadurmuş, İsmail Ertürk, Sema Sezgin Göksu, Ali Murat Tatlı, Deniz Can Güven, Saadettin Kılıçkap, Nail Paksoy, Adnan Aydıner, Havva Yeşil Çınkır, Özlem Özkul, Akın Öztürk, Sevinç Ballı, Yasemi̇n Kemal, Atike Pınar Erdoğan, Özlem Er, Perran Fulden Yumuk, Ahmet Demirkazık

2022Journal of Cancer Research and Clinical Oncology15 citationsDOIOpen Access PDF

Topics & Concepts

AtezolizumabMedicineInternal medicineOncologyLung cancerChemotherapyUnivariate analysisStage (stratigraphy)CancerMultivariate analysisImmunotherapyPembrolizumabPaleontologyBiologyLung Cancer Research StudiesLung Cancer Treatments and MutationsHER2/EGFR in Cancer Research